PREVYMIS
Active substance: letermovir
PELLET · LETERMOVIR 20 mg/1
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LETERMOVIR · 20 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-12bc-7186-9671-a81e79bff2dd,01a1208e-319f-7d5a-82fb-e0508576c8c4,01a1208f-a56f-7ed0-886b-b35abbdd1305,01a12098-2c81-7b33-9a0a-b6b67160dd3b,01a1209a-df80-766a-9f41-503e4540a312;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0006-5086
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0006-5086 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0006-5086 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0006-5086 · Verified 2026-10-09 · open in source